Key Insights

Highlights

Treatment Research

2 treatments under study, led by Sanzkingwill

Research Leaders

5 sponsors active, led by Beijing Chao Yang Hospital

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT04368741Not ApplicableUnknown

Nutrition Product Combine With Continuous Glucose Monitoring in Gestational Diabetes Mellitus Patients

Showing all 1 trials

Research Network

Common Treatments

  • Sanzkingwill1
  • Glucerna Sr1

Active Sponsors

  • Beijing Chao Yang Hospital1
  • Beijing Obstetrics and Gynecology Hospital1
  • Peking Union Medical College Hospital1
  • Sanz Pharmaceutical Group1
  • San MediTech(Huzhou)Co.,Ltd.1

Top Investigators

Related Conditions

  • Sanzkingwill Combined With Cgm Equipment In Gdm Patients1

Activity Timeline